Publications

Here you will find financial publications and latest news on Sartorius Stedim Biotech S.A.

Financial Publications

2024

First-Quarter Results January to March 2024

April 18, 2024

2023 

Full-Year 2023 Results

February 16, 2024

Nine-Month Results January to March 2023

October 19, 2023

Half-Year 2023 Results

July 21, 2023

First-Quarter Results January to March 2023

April 20, 2023

2022

Full-Year 2022 Results

February 17, 2023

Nine-Month Results January to September 2022

October 19, 2022

Half-Year 2022 Results

July 21, 2022

First-Quarter Results January to March 2022

April 21, 2022

2021

Full-Year 2021 Results

February 17, 2022

Nine-Month Results January to September 2021

October 20, 2021

Half-Year 2021 Results

July 21, 2021

First-Quarter Results January to March 2021

April 21, 2021

2020

Full-Year 2020 Results

February 18, 2021

Nine-Month Results January to September 2020

October 20, 2020

Half-Year 2020 Results

July 21, 2020

First-Quarter Results January to March 2020

April 21, 2020

2019

Full-Year 2019 Results

February 18, 2020

Nine-Month Results January to September 2019

October 21, 2019

Half-Year 2019 Results

July 19, 2019

First-Quarter Results January to March 2019

April 18, 2019

2018

Annual Report 2018

February 19, 2019

Nine-Month Results January to September 2018

October 23, 2018

Half-Year Report January to June 2018

July 24, 2018

First-Quarter Results January to March 2018

April 24, 2018

2017

Annual Report 2017

February 20, 2018

Nine-Month Results January to September 2017

October 25, 2017

Half-Year Report January to June 2017

July 21, 2017

First-Quarter Results January to March 2017

April 24, 2017

2016

Annual Report 2016

February 23, 2017

Nine-Month Results January to September 2016

October 24, 2016

Half-Year Report January to June 2016

July 25, 2016

First-Quarter Results January to March 2016

April 20, 2016

2015

Annual Report 2015

February 26, 2016

Nine-Month Results January to September 2015

October 20, 2015

Half-Year Report January to June 2015

July 21, 2015

First-Quarter Results January to March 2015

April 20, 2015

2014

Annual Report 2014

February 27, 2015

Nine-Month Results January to September 2014

October 21, 2014

Half-Year Report January to June 2014

July 22, 2014

First-Quarter Results January to March 2014

April 28, 2014

2013

Annual Report 2013

February 28, 2014

Nine-Month Report January to September 2013

October 21, 2013

Half-Year Report January to June 2013

July 23, 2013

First-Quarter Results January to March 2013

April 23, 2013

Alternative Performance Measures 

Sartorius Stedim Biotech publishes alternative performance measures that are not defined by international accounting standards. These are determined with the aim of improving the comparability of business performance over time and within the industry.

Reconciliation tables are available within the respective quarterly earnings release, half-year financial report or Universal Registration Document and present the composition of adjustments.

Capital expenditures in relation to sales revenue

Figures given in constant currencies eliminate the impact of changes in exchange rates by applying the same exchange rate for the current and the previous period

Equity in relation to the balance sheet total

All customer orders contractually concluded and booked during the respective reporting period

Organic growth figures exclude the impact from changes in exchange rates and changes in the scope of consolidation

Quotient of net debt and underlying EBITDA over the past 12 months, including the pro forma amount contributed by acquisitions for this period

Profit for the period after non-controlling interest, adjusted for extraordinary items and amortization, as well as based on the normalized financial result and the normalized tax rate

Earnings before interest, taxes, depreciation, and amortization and adjusted for extraordinary items

News

Other presentations

Sign Up for Investor Relations News

icon-e-mail
Investors Contact